The staggering cost of doing nothing — implementation of RSV programs in Europe
Section
Event Description
Join this PROMISE event for a thought-provoking discussion on the patient impact of Respiratory Syncytial Virus (RSV), unmet medical needs, and pathways to enhance EU Member State’s immunisation responses.
Mark your calendars for 22nd February between 15:00-16:30, as we bring RSV stakeholders and policymakers together for two panels focusing on the current impact of the virus and use the latest surveillance data to discuss the future policies to beat it.
The first panel “Burden and impact of RSV – the added value of EU co-operation” will debate the burden of RSV on patients, the health systems and society.
During our second panel titled “From research to policy: passing the baton on RSV policy” the discussion will revolve around how we can mitigate the burden of the disease.
Events of the week
Jobs
EURACTIV News
- EU-Mercosur deal ‘in sight’ as von der Leyen lands in Montevideo
- Chasing the spectre of de-industrialisation [Promoted content]
- NGO calls for sales ban on Norwegian salmon in Germany
- China automakers pivot to hybrids for Europe to counter EV tariffs
- EU should regulate land speculators of 4G, 5G antennas, towerco industry says